Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio Are Respectively Associated with Prognosis of Gastric Cancer with Liver Metatasis Undergoing and without Hepatectomy
Table 2
Comparison of survival in operation for all patients of GCLM.
Parameter
All
Yes/High
No/Low
Hepatectomy in all GCLM, Yes : No = 54 : 320
OS (month)
8.0 (16.0)
29.3 (50.5)
6.0 (10.0)
0.001∗
1‐year survival, (%)
135 (36.0%)
42 (77.8%)
93 (29.0%)
0.001∗
3-year survival, (%)
49 (13.1%)
20 (37.0%)
29 (9.0%)
0.001∗
5‐year survival, (%)
25 (6.7%)
14 (25.9%)
11 (3.4%)
0.001∗
PNI in GCLM undergoing hepatectomy, High : Low = 37 : 17
OS (month)
29.3 (50.5)
42.0 (49.0)
12.0 (9.0)
0.001∗
1‐year survival, (%)
42 (77.8%)
33 (89.2%)
9 (52.9%)
0.005∗
3‐year survival, (%)
20 (37.0%)
19 (51.4%)
1 (5.9%)
0.001∗
5‐year survival, (%)
14 (25.9%)
13 (35.1%)
1 (5.9%)
0.020∗
NLR in GCLM without hepatectomy, High : Low = 154 : 166
